Ho Hwang - HansBiomed Chief Executive Officer, Director

042520 Stock  KRW 13,460  30.00  0.22%   

CEO

Hwang Ho Chan is Chief Executive Officer and Director of HANS BIOMED CORPORATION. Hwang used to work for CHINHUNG INTERNATIONAL INC and a Japanbased company. Hwang holds a Bachelor degree in Electrical Engineering from Hongik University, Korea.
Age 56
Phone82 2 466 2266
Webhttps://www.hansbiomed.com

HansBiomed Management Efficiency

The company has return on total asset (ROA) of (0.0946) % which means that it has lost $0.0946 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 13.6473 %, meaning that it generated $13.6473 on every $100 dollars invested by stockholders. HansBiomed's management efficiency ratios could be used to measure how well HansBiomed manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.35 B in total debt with debt to equity ratio (D/E) of 0.73, which is about average as compared to similar companies. HansBiomed has a current ratio of 1.81, which is within standard range for the sector. Debt can assist HansBiomed until it has trouble settling it off, either with new capital or with free cash flow. So, HansBiomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HansBiomed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HansBiomed to invest in growth at high rates of return. When we think about HansBiomed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

CEO Age

Kwangill KohKoh Young Technology
66
YoungJoo HamHana Financial
67
Daehwan KimSamsung Card Co
60
JungTai KimHana Financial
71
Won HongEBEST Investment Securities
48
Gwang GohKoh Young Technology
54
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea. HansBiomed (042520) is traded on KOSDAQ in Korea and employs 15 people.

Management Performance

HansBiomed Leadership Team

Elected by the shareholders, the HansBiomed's board of directors comprises two types of representatives: HansBiomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HansBiomed. The board's role is to monitor HansBiomed's management team and ensure that shareholders' interests are well served. HansBiomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HansBiomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ho Hwang, Chief Executive Officer, Director
Hong Yim, Director
Guen Kim, Chief Officer
Seok Oh, Chief Financial Officer, Assistant Managing Director
Jin Kim, Director
Jun Park, Director
Geun Kim, Internal Auditor
Seong Jeon, Director
Won Gwon, Assistant Managing Director
SeokBae Oh, Chief Director
Yong Cho, Director
Tae Kim, Director
Gye Kang, Director
Seong Park, Director
WonGyun Kwon, MD Director

HansBiomed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HansBiomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HansBiomed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HansBiomed's short interest history, or implied volatility extrapolated from HansBiomed options trading.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HansBiomed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the HansBiomed information on this page should be used as a complementary analysis to other HansBiomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for HansBiomed Stock analysis

When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Please note, there is a significant difference between HansBiomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if HansBiomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HansBiomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.